Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:abbreviation |
gptkb:Primary_Progressive_Multiple_Sclerosis
|
| gptkbp:characterizedBy |
progressive neurological decline
|
| gptkbp:diagnosedBy |
gptkb:neurological_examination
MRI |
| gptkbp:firstDescribed |
late 20th century
|
| gptkbp:fullName |
gptkb:Primary_Progressive_Multiple_Sclerosis
|
| gptkbp:notableDifferenceFrom |
relapsing-remitting multiple sclerosis
|
| gptkbp:onset |
usually after age 40
|
| gptkbp:prevalence |
about 10-15% of MS cases
|
| gptkbp:progression |
steady without relapses
|
| gptkbp:symptom |
balance problems
muscle weakness spasticity bladder dysfunction walking difficulties |
| gptkbp:treatment |
gptkb:ocrelizumab
physical therapy symptomatic management |
| gptkbp:type |
multiple sclerosis
|
| gptkbp:bfsParent |
gptkb:primary_progressive_MS
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
PPMS
|